Literature DB >> 21439447

Diagnosis of multiple sclerosis.

Barbara S Giesser1.   

Abstract

There is no pathognomonic symptom, sign, or paraclinical result that provides an unfailingly accurate diagnosis of multiple sclerosis (MS), and hence, MS remains largely a clinical diagnosis. However, being a clinical diagnosis does not mean that the diagnosis of MS is one of exclusion. Increasingly sophisticated guidelines and objective paraclinical findings are generally sufficient to allow the clinician to confirm or rule out the diagnosis with confidence. This article presents the most recent guidelines for using clinical, radiological, and other paraclinical information and the red flags that should alert the clinician to investigate other diagnostic possibilities.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21439447     DOI: 10.1016/j.ncl.2010.12.001

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

1.  Validation of the Social Provisions Scale in people with multiple sclerosis.

Authors:  Chung-Yi Chiu; Robert W Motl; Nicole Ditchman
Journal:  Rehabil Psychol       Date:  2016-04-18

2.  Quality of life in patients with multiple sclerosis and their caregivers in Colombia: One-year follow-up.

Authors:  Elkin Beltrán; Diana Díaz; Cindy Díaz; Luis Zarco
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

3.  Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.

Authors:  Michael Heming; Andreas Schulte-Mecklenbeck; Tobias Brix; Jolien Wolbert; Tillmann Ruland; Luisa Klotz; Sven G Meuth; Catharina C Gross; Heinz Wiendl; Gerd Meyer Zu Hörste
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

4.  A Rare Case of Spinal Cord Injury Following Thoracic Radiofrequency Ablation.

Authors:  Nicholas K Donohue; Christopher White
Journal:  Cureus       Date:  2021-06-01

Review 5.  Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.

Authors:  Elmira Agah; Arshia Zardoui; Amene Saghazadeh; Mona Ahmadi; Abbas Tafakhori; Nima Rezaei
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

6.  Falls in people with multiple sclerosis: experiences of 115 fall situations.

Authors:  Anna Carling; Anette Forsberg; Ylva Nilsagård
Journal:  Clin Rehabil       Date:  2017-09-13       Impact factor: 3.477

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.